Analysis
$17Q1 analysis on 6ix - valuation, growth, dividend & more for Pharmaron Beijing Co., Ltd. Class A
Track Pharmaron Beijing Co., Ltd. Class A (17Q1) on 6ix - releases, events, and the audience already following the stock.
Pharmaron Beijing Co., Ltd. Class A
Run a Simply Wall St-style analysis on $17Q1 (Pharmaron Beijing Co., Ltd. Class A) - valuation, growth, past performance, dividend, ownership, and community ...